Skip to main content

Closed

HOTH: Hoth Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-277.2%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio3.39×

Hoth Therapeutics, Inc.

HOTHNASDAQ·USD·Closed

Hoth Therapeutics, Inc.

HOTHNASDAQ·USD·Closed

$0.79

+0.16%

$0.79

+$0.00 (0.16%)

52W Range

15thpctl

Volume

0.04×avg

Mkt Cap

10.51MUSD

P/E

-1.0TTM

Div Yield

–ann

52W Range

15thpctl

Volume

0.04×avg

Market Cap

10.51MUSD

P/E Ratio

-1.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings